Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-to-Present-at-Upcoming-Investor-Conferences/default.aspx
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2021
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2021-Results-LINZESS-linaclotide-Achieves-Blockbuster-Status-as-U.S.-Net-Sales-Exceed-1-Billion-in-2021/default.aspx
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2021
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2021-Results-LINZESS-linaclotide-Achieves-Blockbuster-Status-as-U.S.-Net-Sales-Exceed-1-Billion-in-2021/default.aspx
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-to-Host-Fourth-Quarter-and-Full-Year-2021-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-to-Host-Fourth-Quarter-and-Full-Year-2021-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-Provides-Update-on-FY-2021-Financial-Guidance-and-Announces-FY-2022-Financial-Guidance/default.aspx
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-Provides-Update-on-FY-2021-Financial-Guidance-and-Announces-FY-2022-Financial-Guidance/default.aspx
Ironwood Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-to-Present-at-the-40th-Annual-J.P.-Morgan-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-to-Present-at-the-40th-Annual-J.P.-Morgan-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals Appoints Sravan K. Emany as Chief Financial Officer
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Appoints-Sravan-K.-Emany-as-Chief-Financial-Officer/default.aspx